Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - OPERATING INCOME
Operating Income ADAP - Adaptimmune Therapeutics plc
-138 M
LAST VALUE
7.76%
2 YEAR CAGR
-10.88%
5 YEAR CAGR
-30.89%
10 YEAR CAGR